垂体卒中病例系列:单中心内镜下经鼻蝶入路手术后结局
该研究回顾性分析2012至2018年单中心50例接受内镜下经鼻蝶入路手术的垂体卒中患者,平均年龄53岁,平均随访26个月。术后头痛和视力丧失改善率分别为87%和86%,颅神经麻痹72%完全缓解,无死亡或颈动脉损伤,但48%患者全垂体功能减退持续存在。
要点
- 内镜下经鼻蝶入路手术可快速改善垂体卒中患者的头痛和视力症状。
- 术后48%患者全垂体功能减退持续存在,6%新发全垂体功能减退。
- 无死亡或颈动脉损伤,术后脑脊液漏发生率为8%。
核心结论
- 内镜下经鼻蝶入路手术治疗垂体卒中可有效快速改善头痛和视觉症状。
- 尽管神经眼科缺损常随时间改善,但多数患者术后全垂体功能减退持续存在。
研究设计与样本
- 回顾性综述,纳入2012至2018年本机构临床及影像/病理诊断的垂体卒中并接受内镜下经鼻蝶入路手术的患者50例,平均年龄53岁。
主要发现
- 术前症状包括头痛86%、视力丧失62%、颅神经麻痹40%;平均肿瘤直径2.7 cm,96%肿瘤有鞍外 extension。
- 28例肿瘤出血(76%),24例坏死(65%),13例(35%)兼有两者。
- 磁共振成像显示58%患者达到大体全切除。
- 头痛和视力丧失在就诊患者中分别改善87%和86%;颅神经麻痹72%完全缓解,11%部分改善,17%无变化。
- 术后并发症包括脑脊液漏4例(8%)、鼻出血2例(4%)、术后脓肿1例(2%)、需再次手术的短暂术后视力丧失1例(4%);无死亡或颈动脉损伤。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The management of pituitary apoplexy, caused by acute hemorrhage and/or infarction of a pituitary adenoma, is debated. OBJECTIVE: To analyze clinical characteristics of patients undergoing endoscopic endonasal approaches (EEAs) for pituitary apoplexy. METHODS: A retrospective review of patients at our institution from 2012 to 2018 undergoing EEA for pituitary apoplexy diagnosed clinically and with imaging/pathologic findings. Analysis included demographics, symptoms, neuroendocrine deficits, neuroimaging, complications, symptom resolution, and follow-up details. RESULTS: Fifty patients (mean age, 53 years) were included. Preoperative symptoms included headache (86%), vision loss (62%), and cranial nerve paresis (40%). Mean tumor diameter was 2.7 cm and extrasellar extension was observed in 96% of tumors. Twenty-eight tumors were hemorrhagic (76%), 24 were necrotic (65%), and 13 (35%) had both features. Magnetic resonance imaging showed gross total resection in 58% of patients. Headache and vision loss improved in 87% and 86% of presenting patients. Cranial nerve paresis resolved in 72% of patients, partially improved in 11%, and remained unchanged in 17%. There were no deaths or carotid artery injuries. Surgical complications included postoperative cerebrospinal fluid leak (n = 4, 8%), epistaxis (n = 2, 4%), postoperative abscess (n = 1, 2%), and transient postoperative vision loss requiring reoperation (n = 1, 4%). Endocrinopathies improved in 21% of patients and panhypopituitarism persisted in 48% and developed in 6% of patients. Mean follow-up time was 26 months; 2 patients experienced recurrence. CONCLUSIONS: EEA for pituitary apoplexy is effective in rapidly improving headache and visual symptoms. Although neuro-ophthalmic deficits often improve over time, panhypopituitarism persists in most patients after surgical resection.
引用
- Pangal DJ, Chesney K, Memel Z, et al. Pituitary Apoplexy Case Series: Outcomes After Endoscopic Endonasal Transsphenoidal Surgery at a Single Tertiary Center. World Neurosurg. 2020. PMID: 32032792. doi:10.1016/j.wneu.2020.01.204
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。